Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > January 2004

« Previous month Next month »

Agilent to roll out first-in-class QA/QC software

30-Jan-2004 - Agilent Technologies has launched a software package to help drug companies keep a close eye on the quality of chemical compounds. The firm says the product is the first of...

Dow swings to profit as revenues surge

30-Jan-2004 - Dow said that increased demand for its products lifted fourth-quarter sales by 20 per cent to $8.3 billion (€6.67bn), well ahead of analysts' consensus estimates of $7.88 billion.

Chr Hansen sales pegged back by dollar

30-Jan-2004 - Danish company Chr Hansen saw its revenues slip 4 per cent in its first quarter, as the impact of the economic downturn and tough dollar exchange rate was felt across...

Algry planning pharma charge

30-Jan-2004 - Spanish manufacturer of choline salts Algry Quimica has signed several new research agreements to develop active ingredients for pharma and food applications.

Euro chemicals gathers momentum

30-Jan-2004 - UK chemical sector growth, including pharmaceuticals, is forecast at 3.6 per cent for 2004, outperforming the 2.3 per cent growth estimated for Europe as a whole, according to a study...

Pros and cons of Sanofi-Aventis link

30-Jan-2004 - Sanofi's hostile bid for larger French rival Aventis may have been rejected, but there are a number of arguments in favour of a link, according to analyst Nicole Lamble at...

Honeywell to source solvents from Korea

28-Jan-2004 - Honeywell has signed a deal with Korea's SK Chemicals that will expand its production of high-purity solvents in Asia.

Millipore and HyClone link up on 'plastic factory' project

28-Jan-2004 - Millipore has teamed up with HyClone Laboratories in an alliance that brings the concept of disposable factory for biopharmaceuticals production a step closer.

Monsanto strikes back in Solutia dispute

28-Jan-2004 - Monsanto and Pfizer's Pharmacia subsidiary have asked a federal judge to either deny or postpone a request by Solutia to eliminate liabilities to its former parent Monsanto.

Metal detector solves blister pack problem

28-Jan-2004 - A new metal detector capable of picking up ferrous and stainless steel contamination within aluminium foil wrapped products has been developed. Manufactured by German technology firm Sartorius, the product, called...

Tetrionics ramps up potent API business

28-Jan-2004 - Active pharmaceutical ingredient manufacturer Tetrionics is planning to double the capacity at a facility in the US to hike its ability to make highly potent compounds.

Tackling side effects with drug delivery

28-Jan-2004 - A small US company has developed an encapsulation technology for pharmaceuticals that promises to overcome a major healthcare problem - deaths and illness caused by aspirin and other non-steroidal anti-inflammatory...

Strong revenue growth at Millipore

27-Jan-2004 - Filtration specialist Millipore has reported strong growth in sales in the fourth quarter of 2003, suggesting that the fortunes of the biopharmaceutical industry - Millipore's primary customer - may be...

UK chemicals body gears up for REACH

27-Jan-2004 - The Chemical Industries Association in the UK has unveiled plans to develop a database of chemicals marketed in the UK as part of the industry's preparations for the adoption of...

Gradiflow separation passes early test

27-Jan-2004 - Australia's Gradipore has been boosted by news that its Gradiflow separation technology has been scaled up to produce commercial quantities of an antibody from source plasma.

New venture to tackle oral film delivery

27-Jan-2004 - MonoSol has set up a new venture, called MonoSolRx, aimed at developing oral film strip technologies for use in the delivery of drugs.

Faster, nanoscale HPLC from Eksigent

27-Jan-2004 - Eksigent Technologies is launching a new high-pressure liquid chromatography system in March that can increase throughput compared to rival HPLC systems as much as six-fold.

Pharma tech growing strongly at Cardinal

26-Jan-2004 - Healthcare giant Cardinal Health reported revenues up 11 per cent to $14.1 billion (€11.2bn) in the fourth-quarter of 2003, as a strong performance in its pharmaceutical manufacturing services, pharmacy automation...

New team in chiral alcohols

26-Jan-2004 - Germany's Wacker Specialties has signed an R&D agreement with Finland's Prokaria to bolster its activities in chiral alcohols, used as chemical building blocks by the pharmaceutical industry.

Sanofi gets hostile with Aventis bid

26-Jan-2004 - French pharmaceutical company Sanofi-Synthelabo has launched a hostile takeover bid for its larger rival Aventis, in a move which would create a top three drug major.

APIs prop up Bachem in 2003

26-Jan-2004 - Switzerland's Bachem saw its 2003 sales slip by 3 per cent as continued slack demand for research chemicals held back a modest increase in its active pharmaceutical ingredients business.

India set to dominate generic API market?

26-Jan-2004 - Last year, pharmaceutical companies from India submitted a third of all the Drug Master Files for active pharma ingredients (APIs) received in the US, outstripping their international rivals by a...

Male contraceptive trials get underway

22-Jan-2004 - Germany's Schering and Organon of the Netherlands have started a Phase II trial of a hormonal implant designed to block fertility in men.

New enzymes for chiral alcohols

22-Jan-2004 - BioCatalytics has expanded its product line of enzymes for chemical synthesis with the addition of new ketoreductases (KRED) enzymes for the stereoselective reduction of ketones.

AstraZeneca extends oral profiling deal

22-Jan-2004 - AstraZeneca has extended an agreement with UK-based Cyprotex to bulk screen whether its drug candidates for suitable for oral administration.

« Previous month Next month »

Key Industry Events


Access all events listing

Our events, Shows & Conferences...